COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW
Autor: | Obaid Ur Rahman, Muhammad Umar Amin, Mohsin Saif, Hamid Sharif Khan, Qamar-Uz-Zaman Bhatti, Ghulam Rasool Maken, Anam Fatima Janjua, Zohair Aziz, Sohail Aziz |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Medicine (General) Cath lab medicine.medical_treatment pci nstemi law.invention thrombolysis in myocardial infarction flow R5-920 Randomized controlled trial law Internal medicine Angioplasty medicine Myocardial infarction cardiovascular diseases business.industry Percutaneous coronary intervention Thrombolysis medicine.disease stemi Conventional PCI Cardiology cardiovascular system Verapamil Medicine no-reflow business medicine.drug |
Zdroj: | Pakistan Armed Forces Medical Journal, Vol 70, Iss 4, Pp 833-837 (2020) |
ISSN: | 2411-8842 0030-9648 |
Popis: | Objective: To determine the efficacy of intracoronary verapamil vs adenosine in restoration of coronary blood flow, post PCI in patients with No-Reflow. Study Design: Double blind (patient/operator blind) randomized control trial. Place and Duration of Study: Cath lab of AFIC & NIHD Rawalpindi, from Feb 2019 to Aug 2019. Methodology: A total of ninety (n=90) patients of either gender between age 25-80 years of age who underwent angioplasty for STEMI/NSTEMI demonstrating No-Reflow (thrombolysis in myocardial infarction 0,1,2) post PCI were enrolled and were randomized into two groups. Group A received verapamil 500 µg in 10 ml heparinized saline, given slowly over 1 minute and group B received adenosine 60 µg in 10 ml of heparinized saline, given quickly. After the administration of both drugs repeat angiogram was carried out and thrombolysis in Myocardial Infarction flow was assessed. Restoration of blood flow was defined as achievement of thrombolysis in myocardial infarction 3 grade. Results: Efficacy (restoration of thrombolysis in Myocardial Infarction grade 3) was better with intracoronary administration of verapamil when compared with intracoronary administration 2 of adenosine (84.4% vs 80%). The difference was, however, not statistically significant (p=0.581). Conclusion: Efficacy (restoration of thrombolysis in myocardial infarction grade 3) was not statistically significant between intracoronary administration of verapamil and adenosine in no-reflow cases after PCI in patients with STEMI/NSTEMI. |
Databáze: | OpenAIRE |
Externí odkaz: |